What is the category of Nippon India Pharma Fund - Direct Plan - Growth Plan ? The category of Nippon India Pharma Fund - Direct Plan - Growth Plan is Equity - Sector - Healthcare What is the ...

a law firm whose specialties include pursuing pharmaceutical drug injury cases. Ethics records released Wednesday indicate that Kennedy intends to keep collecting fees related to past referrals of ...

A well-crafted narrative can make your product more relatable and memorable, helping it stand out in a crowded marketplace. A product’s story can include the inspiration behind its creation, the ...

To sustain this momentum and achieve the government’s $50 billion export target by 2030, it is essential to promote exports of pharma product as well as research and manufacturing services.

announced the launch Phytonadione Injectable Emulsion. The aforementioned drug is bioequivalent and therapeutically equivalent to the reference listed drug Vitamin K1 Injectable Emulsion USP of ...

To fulfill a need for new professionals in the growing South Carolina life science industry, Ritedose partnered with Newberry College to develop a Pharmaceutical Manufacturing program.

It is expected that a reusable heavy-lift rocket, named the Long March-9, will be required to launch the solar farm into orbit. Once in place, this one-kilometre-wide solar array is expected to ...

India's pharmaceutical industry holds immense promise ... For context, the government has set a target to increase healthcare expenditure to 2.5% of the country's gross domestic product (GDP) by 2025, ...

The time to market has become more crucial in the pharmaceutical sector. According to the research, the first six months after launch typically capture 60% of a product's lifetime revenue potential.